Search for other papers by Olav Inge Håskjold in
Google Scholar
PubMed
Search for other papers by Henrik Stenestø Foshaug in
Google Scholar
PubMed
Search for other papers by Therese Benedikte Iversen in
Google Scholar
PubMed
Search for other papers by Helga Charlotte Kjøren in
Google Scholar
PubMed
UiT – The Arctic University of Norway, Institute of Clinical Medicine
Search for other papers by Vegard Heimly Brun in
Google Scholar
PubMed
Introduction Surgery of the thyroid gland can be indicated because of compression symptoms, thyrotoxicosis, or cancer. However, typically 35–40% of surgeries in Europe are made when examination including fine-needle cytology (FNC) biopsy fail
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Xu-Feng Chen in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Cong He in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Peng-Cheng Yu in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Wei-Dong Ye in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Pei-Zheng Han in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Jia-Qian Hu in
Google Scholar
PubMed
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of China
Search for other papers by Yu-Long Wang in
Google Scholar
PubMed
clinical practice. NGS reveals the comprehensive genetic background of a certain tumor, thus assisting tumor diagnosis and treatment. Thyroid cancer is the most common endocrine malignancy with an increasing incidence ( 2 ) in recent decades. Exciting
Search for other papers by Wei Li in
Google Scholar
PubMed
Search for other papers by Qing Huang in
Google Scholar
PubMed
Search for other papers by Danyang Sun in
Google Scholar
PubMed
Search for other papers by Guizhi Zhang in
Google Scholar
PubMed
Search for other papers by Jian Tan in
Google Scholar
PubMed
Introduction Papillary thyroid carcinoma (PTC) is the most common subtype of thyroid cancer. In 2008, the incidence of thyroid cancer was 1.4/100,000, and it accounts for 0.8% of all malignancies in China (0.4% of those in men, 1.3% in women
The Clatterbridge Cancer Centre, Wirral, UK
Search for other papers by Anna Olsson-Brown in
Google Scholar
PubMed
Search for other papers by Rosemary Lord in
Google Scholar
PubMed
Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
Search for other papers by Joseph Sacco in
Google Scholar
PubMed
Search for other papers by Jonathan Wagg in
Google Scholar
PubMed
Search for other papers by Mark Coles in
Google Scholar
PubMed
Search for other papers by Munir Pirmohamed in
Google Scholar
PubMed
course of thyroid dysfunction in patients from a single, UK regional cancer centre to determine if there is a characteristic pattern of biochemical abnormality, the proportion of patients experiencing clinically significant symptoms and the relationship
Department of Nuclear Medicine, CHU de Bordeaux, Pessac, France
INRA, Nutrition et Neurobiologie Intégrée, UMR1286, Bordeaux, France
Search for other papers by J Brossaud in
Google Scholar
PubMed
INRA, Nutrition et Neurobiologie Intégrée, UMR1286, Bordeaux, France
Search for other papers by V Pallet in
Google Scholar
PubMed
Department of Nuclear Medicine, CHU de Bordeaux, Pessac, France
INRA, Nutrition et Neurobiologie Intégrée, UMR1286, Bordeaux, France
Search for other papers by J-B Corcuff in
Google Scholar
PubMed
probably its potential therapeutic use in thyroid cancer. The rational for this interest is precisely the potential ability of RA isoforms to sustain cell differentiation or to reverse cell dedifferentiation in various models of cancer. With regards to a
Search for other papers by Louise Vølund Larsen in
Google Scholar
PubMed
Search for other papers by Delphine Mirebeau-Prunier in
Google Scholar
PubMed
Search for other papers by Tsuneo Imai in
Google Scholar
PubMed
Search for other papers by Cristina Alvarez-Escola in
Google Scholar
PubMed
Search for other papers by Kornelia Hasse-Lazar in
Google Scholar
PubMed
Search for other papers by Simona Censi in
Google Scholar
PubMed
Search for other papers by Luciana A Castroneves in
Google Scholar
PubMed
Search for other papers by Akihiro Sakurai in
Google Scholar
PubMed
Search for other papers by Minoru Kihara in
Google Scholar
PubMed
Search for other papers by Kiyomi Horiuchi in
Google Scholar
PubMed
Réseau TenGen, Marseille, France
Search for other papers by Véronique Dorine Barbu in
Google Scholar
PubMed
Fédération d’Endocrinologie, Hospices Civils de Lyon, Université Lyon 1, France
Search for other papers by Francoise Borson-Chazot in
Google Scholar
PubMed
Service de Génétique, AP-HP, Hôpital européen Georges Pompidou, Paris, France
Université de Paris, PARCC, INSERM, Paris, France
Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Laboratoire de Biochimie et Oncologie Moléculaire, CHU Lille, Lille, France
Search for other papers by Pascal Pigny in
Google Scholar
PubMed
Laboratoire de Génétique Moléculaire, CHU Lyon, Lyon, France
Search for other papers by Stephane Pinson in
Google Scholar
PubMed
Search for other papers by Nelson Wohllk in
Google Scholar
PubMed
Search for other papers by Charis Eng in
Google Scholar
PubMed
Search for other papers by Berna Imge Aydogan in
Google Scholar
PubMed
Search for other papers by Dhananjaya Saranath in
Google Scholar
PubMed
Search for other papers by Sarka Dvorakova in
Google Scholar
PubMed
Department of Endocrinology, Assistance Publique-Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de Référence des Maladies Rares de l’hypophyse HYPO, Marseille, France
Search for other papers by Frederic Castinetti in
Google Scholar
PubMed
Search for other papers by Attila Patocs in
Google Scholar
PubMed
Search for other papers by Damijan Bergant in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Mariola Peczkowska in
Google Scholar
PubMed
Search for other papers by Ana O Hoff in
Google Scholar
PubMed
Search for other papers by Caterina Mian in
Google Scholar
PubMed
Search for other papers by Trisha Dwight in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Search for other papers by Hartmut P H Neumann in
Google Scholar
PubMed
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Search for other papers by Shinya Uchino in
Google Scholar
PubMed
Aix Marseille Univ, APHM, INSERM, MMG, Laboratory of Molecular Biology, Hospital La Conception, Marseille, France
Search for other papers by Anne Barlier in
Google Scholar
PubMed
Search for other papers by Christian Godballe in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Jes Sloth Mathiesen in
Google Scholar
PubMed
Committee on Cancer seventh edition ( 31 ). d Malignant. CLA, cutaneous lichen amyloidosis; HSCR, Hirschsprung disease; MEN 2A, multiple endocrine neoplasia type 2A; MTC, medullary thyroid carcinoma; N, no; NA, not available; PHEO, pheochromocytoma
Search for other papers by Malgorzata Oczko-Wojciechowska in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Tomasz Gawlik in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Search for other papers by Jolanta Krajewska in
Google Scholar
PubMed
Introduction Medullary thyroid cancer (MTC) is a rare, malignant neoplasm from the C-cell of the thyroid, which occurs in sporadic and hereditary forms. Hereditary MTC develops in the course of MEN2A and MEN2B syndromes due to germline
Search for other papers by Camila Aparecida Moma in
Google Scholar
PubMed
Search for other papers by Icléia Siqueira Barreto in
Google Scholar
PubMed
Search for other papers by Ligia Vera Montali Assumpção in
Google Scholar
PubMed
Search for other papers by Denise Engelbrecht Zantut-Wittmann in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common endocrine neoplasm, corresponding to 3.4% of all malignant neoplasms diagnosed annually. About 90% are differentiated tumors derived from thyroid follicular cells ( 1 , 2 , 3 ). In recent
Search for other papers by Bliss Anderson in
Google Scholar
PubMed
Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
-checkpoint inhibitors . Cancer Science 2020 111 1468 – 1477 . ( https://doi.org/10.1111/cas.14363 ) 48 Frelau A Palard-Novello X Jali E Boussemart L Dupuy A James P Devillers A Le Jeune F Edeline J Lesimple T Increased thyroid uptake on 18
Postgraduate Program in Health Sciences, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
Search for other papers by Luis Eduardo Barbalho de Mello in
Google Scholar
PubMed
Search for other papers by Thaise Nayane Ribeiro Carneiro in
Google Scholar
PubMed
Search for other papers by Aline Neves Araujo in
Google Scholar
PubMed
Search for other papers by Camila Xavier Alves in
Google Scholar
PubMed
Search for other papers by Pedro Alexandre Favoretto Galante in
Google Scholar
PubMed
Search for other papers by Vanessa Candiotti Buzatto in
Google Scholar
PubMed
Department of Clinical and Toxicological Analyses, Natal, Rio Grande do Norte, Brazil
Search for other papers by Maria das Graças de Almeida in
Google Scholar
PubMed
Search for other papers by Karina Marques Vermeulen-Serpa in
Google Scholar
PubMed
Department of Nutrition, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
Search for other papers by Sancha Helena de Lima Vale in
Google Scholar
PubMed
Search for other papers by Fernando José de Pinto Paiva in
Google Scholar
PubMed
Search for other papers by José Brandão-Neto in
Google Scholar
PubMed
Search for other papers by Janete Maria Cerutti in
Google Scholar
PubMed
Introduction Thyroid cancers arising from follicular cells are referred to as non-medullary thyroid cancer (NMTC), while those arising from parafollicular cells are referred to as medullary thyroid cancer (MTC). Although the majority (~95%) of